Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 3 Comparison of differences in inflammatory related characteristics: Metronidazole + Levofloxacin vs. Unused

From: Antibiotics versus Non-Antibiotic in the treatment of Aspiration Pneumonia: analysis of the MIMIC-IV database

Inflammation Characteristics

Unused (N = 703)

Metronidazole + Levofloxacin (N = 41)

p

platelet (median [IQR])

215.00 [162.50, 278.00]

243.00 [188.00, 286.00]

0.128

po2 (median [IQR])

125.00 [81.00, 225.50]

89.00 [68.00, 226.00]

0.03

pco2 (median [IQR])

40.00 [35.00, 47.00]

43.00 [38.00, 49.00]

0.087

wbc (median [IQR])

9.90 [7.40, 13.30]

9.80 [7.70, 13.20]

0.728

rbc (median [IQR])

4.10 [3.47, 4.58]

3.91 [3.52, 4.49]

0.503

lymphocytes (median [IQR])

11.60 [6.95, 19.30]

10.40 [7.00, 16.00]

0.201

monocytes (median [IQR])

5.40 [3.85, 7.65]

5.60 [2.70, 7.40]

0.379

neutrophils (median [IQR])

80.10 [71.25, 86.45]

83.00 [73.80, 89.10]

0.08

basophils (median [IQR])

0.30 [0.20, 0.50]

0.20 [0.10, 0.40]

0.124

eosinophils (median [IQR])

0.60 [0.10, 1.50]

0.30 [0.10, 1.10]

0.117

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us